A 15-year Retrospective Study of DRESS Syndrome: A Single Center Study.
- Author:
Soo Kyung LEE
1
;
Myoung Shin KIM
;
Un Ha LEE
;
Hai Jin PARK
Author Information
1. Department of Dermatology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea. etihwevol@naver.com
- Publication Type:Original Article
- Keywords:
Adverse drug reaction;
Drug hypersensitivity;
Drug reaction with eosinophilia and systemic symptoms;
Systemic steroid
- MeSH:
Allopurinol;
Anti-Bacterial Agents;
Anticonvulsants;
Aspartate Aminotransferases;
Diagnosis;
Drug Hypersensitivity;
Drug Hypersensitivity Syndrome*;
Drug-Related Side Effects and Adverse Reactions;
Exanthema;
Humans;
Medical Records;
Prognosis;
Retrospective Studies*
- From:Korean Journal of Dermatology
2017;55(8):490-496
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a syndrome involving multiple organs. Due to a variable clinical presentation and uncertain definition, diagnosis is often delayed or misdiagnosed. OBJECTIVE: The purpose of this study was to investigate the common causative drugs of DRESS and differences according to drugs, clinical features, and prognosis of DRESS, and secondly to compare the differences between steroid use group versus non-use group. METHODS: Medical records of hospitalized patients at the Sanggye Paik Hospital from January 2001 to December 2015 were collected. DRESS patients were enrolled retrospectively using the RegiSCAR diagnostic criteria. RESULTS: A total of 65 patients were included. The four most common causative drug groups were antibiotics (27.7%), anticonvulsants (20%), antituberculosis agents (16.9%), and allopurinol (16.9%). The mean incubation period was 4 weeks, significantly shorter in antibiotics (2 weeks, p < 0.001) and significantly longer in anticonvulsants (6.5 weeks, p=0.033). Sixty-three patients fully recovered with a mean recovery time of 3.1 (standard deviation 2.2) weeks, one patient had sequelae, and one patient died. Recovery time tended to increase with longer duration of diagnosis from rash onset (p < 0.001, correlation coefficient=0.419) and higher serum aspartate aminotransferase levels (p=0.024, correlation coefficient=0.297). The mean recovery time was 1 week shorter for the systemic steroid use group, but it was not statistically significant (p=0.056). CONCLUSION: DRESS may be a heterogeneous syndrome with specific characteristics related to different drugs. The prognosis of DRESS is relatively good and the role of systemic steroid therapy is unclear. Prompt diagnosis and immediate discontinuation of the causative drug are essential for early recovery.
